Astera Labs (NASDAQ:ALAB – Get Free Report) is expected to be releasing its earnings data after the market closes on Monday, February 10th. Analysts expect Astera Labs to post earnings of $0.26 per share and revenue of $127.91 million for the quarter. Parties interested in registering for the company’s conference call can do so using this link.
Astera Labs Stock Performance
Astera Labs stock opened at $101.29 on Friday. Astera Labs has a fifty-two week low of $36.22 and a fifty-two week high of $147.39. The firm’s 50-day simple moving average is $122.43 and its 200 day simple moving average is $81.37.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the company. Stifel Nicolaus raised their target price on Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Citigroup assumed coverage on shares of Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective on the stock. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Craig Hallum raised their price target on shares of Astera Labs from $75.00 to $105.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Astera Labs has an average rating of “Buy” and an average price target of $107.42.
Insider Transactions at Astera Labs
In related news, Director Stefan A. Dyckerhoff sold 197,297 shares of the business’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $90.51, for a total transaction of $17,857,351.47. Following the transaction, the director now owns 6,148 shares in the company, valued at $556,455.48. The trade was a 96.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, General Counsel Philip Mazzara sold 2,513 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $90.81, for a total transaction of $228,205.53. Following the completion of the sale, the general counsel now owns 248,745 shares of the company’s stock, valued at $22,588,533.45. This trade represents a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 846,452 shares of company stock worth $86,427,256.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- Stock Splits, Do They Really Impact Investors?
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- How to Buy Cheap Stocks Step by Step
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.